News About: Pharm. Industry
A survey: 6 in 10 Koreans to take medicine if in sex problem.
Quite a number of Korean men and women have experienced a stress of the sexual relations with their partners. When refusing a sexual proposal from the partner, men mostly lied as saying "No good physical conditions" w...
Bayer Korea will turns to street campaigns for Levitra
Bayer Korea said on November 28 it will strengthen marketing efforts to increase the number of Levitra consumers in December, this time through street campaigns rather than 'thumb campaigns and symposia'.
When it ...
Daewoong unveils new liquefied-form analgesicDaewoong Pharm rolled out a new liquefied-form analgesic EGN6 containing dexibuprofen, a non-steroidal anti-inflammatory (NSAID), analgesic, and antipyretic (fever reducing) dru...
|
KPMA to oppose extended patent terms.
In the 5th Korea and U. S. FTA meeting on Dec. 4 the KPMA made it clear not to accept the U. S. request for the extended patent terms and its scope.
The KPMA claimed that the Korean regulatory should notify it to ...
Can Lilly Korea sever ties with Daewoong?
Lilly Korea said on November 27 its U.S. multinational pharmaceutical company Eli Lilly is still considering maintaining its strategic ties with Daewoong Pharm over the co-marketing issue of Cialis as there is a rumor...
Government urged to promote use of generic drugs
The government should focus on encouraging domestic drug companies to develop and market as many generic drugs as possible to reduce drug costs covered by National Health Insurance, instead of pursuing a series of pri...
Government's supporting policies for drug industry doubtful.
The government earlier nominated the pharmaceutical industry as a long term national industrial driving engine but in fact this policy seemed to go adversely or rather demolishing the whole industry.
In view of i...
AstraZeneca Korea accepts price cut of Iressa
AstraZeneca Korea said on November 24 it would not to appeal the ruling of the Seoul Administration Court, while accepting the readjusted price of Iressa (gefitinib) at 55,003 won per tablet to avoid any confusion of ...
Government is likely to reduce generic price by 20%
The government will likely exclude drugs of low quality from the insurance-covered drug lists by reducing their prices by 20 percent in conjunction with the patent-off brands, dealing a blow to small and uncompetitive...
Janssen Korea, Samjin attack cold medicine market with new packages
As the safety containers for children should be equipped with the new pediatric drugs containing acetaminophen or ibuprofen, the domestic market for cold medicines will be contested by two markers Janssen Korea and S...
